373 related articles for article (PubMed ID: 6800645)
61. Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.
Neal GE; Colley PJ
Biochem J; 1978 Sep; 174(3):839-51. PubMed ID: 728090
[TBL] [Abstract][Full Text] [Related]
62. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
Guarisco JA; Hall JO; Coulombe RA
Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
[TBL] [Abstract][Full Text] [Related]
63. Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers.
Sunouchi M; Fukuhara M; Ohno Y; Takanaka A
J Toxicol Sci; 1988 Nov; 13(4):193-204. PubMed ID: 3149679
[TBL] [Abstract][Full Text] [Related]
64. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.
Lin JK; Miller JA; Miller EC
Cancer Res; 1977 Dec; 37(12):4430-8. PubMed ID: 922734
[No Abstract] [Full Text] [Related]
65. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
66. Developmental toxicity of aflatoxin B1 in the rodent embryo in vitro: contribution of exogenous biotransformation systems to toxicity.
Geissler F; Faustman EM
Teratology; 1988 Feb; 37(2):101-11. PubMed ID: 3127910
[TBL] [Abstract][Full Text] [Related]
67. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
Irvin TR; Wogan GN
Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
[TBL] [Abstract][Full Text] [Related]
68. [Effects of harman and norharman on aflatoxin B1 and aminopyrine metabolism by phenobarbital and 3-methylcholanthrene-induced rat liver microsomes].
Lin DX
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Jul; 26(4):209-12. PubMed ID: 1302193
[TBL] [Abstract][Full Text] [Related]
69. Long-term effects of neonatal phenobarbital exposure on aflatoxin b1 disposition in adult rats.
Faris RA; Campbell TC
Cancer Res; 1983 Jun; 43(6):2576-83. PubMed ID: 6406048
[No Abstract] [Full Text] [Related]
70. The effect of pre-treatment with phenobarbitone on the activation of aflatoxin B1 by rat liver.
Neal GE; Godoy HM
Chem Biol Interact; 1976 Aug; 14(3-4):279-89. PubMed ID: 954146
[TBL] [Abstract][Full Text] [Related]
71. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.
Buening MK; Chang RL; Huang MT; Fortner JG; Wood AW; Conney AH
Cancer Res; 1981 Jan; 41(1):67-72. PubMed ID: 7448777
[TBL] [Abstract][Full Text] [Related]
72. Metabolism of aflatoxin B1 in the bovine olfactory mucosa.
Larsson P; Pettersson H; Tjälve H
Carcinogenesis; 1989 Jun; 10(6):1113-8. PubMed ID: 2498000
[TBL] [Abstract][Full Text] [Related]
73. Species comparison of in vitro metabolism of aflatoxin B1.
Roebuck BD; Wogan GN
Cancer Res; 1977 Jun; 37(6):1649-56. PubMed ID: 404034
[TBL] [Abstract][Full Text] [Related]
74. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis.
Essigmann JM; Croy RG; Bennett RA; Wogan GN
Drug Metab Rev; 1982; 13(4):581-602. PubMed ID: 6813091
[No Abstract] [Full Text] [Related]
75. Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450.
Miller RE; Guengerich FP
Cancer Res; 1983 Mar; 43(3):1145-52. PubMed ID: 6825087
[TBL] [Abstract][Full Text] [Related]
76. A comparison of the effects of aflatoxin B1 on the livers of rats and duck hepatitis B virus-infected and noninfected ducks.
Seawright AA; Snowden RT; Olubuyide IO; Riley J; Judah DJ; Neal GE
Hepatology; 1993 Jul; 18(1):188-97. PubMed ID: 8325610
[TBL] [Abstract][Full Text] [Related]
77. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
[TBL] [Abstract][Full Text] [Related]
78. Purification and characterization of a hepatic mitochondrial cytochrome P-450 active in aflatoxin B1 metabolism.
Shayiq RM; Avadhani NG
Biochemistry; 1989 Sep; 28(19):7546-54. PubMed ID: 2514788
[TBL] [Abstract][Full Text] [Related]
79. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
80. Effect of senescence on the bioactivation of aliphatic halides.
DiRenzo AB; Gandolfi AJ; Sipes IG; McDougal JN
Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):493-502. PubMed ID: 6812184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
